Skip to content

Use of Amalaki seed paste in leucorrhea

Evaluation of Amalaki beej kalka in shweta pradara (LEUCORRHEA): A single arm clinical study.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049567
Enrollment
44
Registered
2023-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N888- Other specified noninflammatory disorders of cervix uteri

Interventions

None listed

Sponsors

DR. PADMAJA KALE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Females under reproductive age group of 18-45 years. 2. Female Patients with excessive amount of watery or mucoid vaginal white discharge. 3. Non purulent and non- offensive vaginal discharge. 4. Patients with chronic Pelvic Inflammatory Disease.

Exclusion criteria

Exclusion criteria: 1. Pregnant women. 2. Positive history of Venereal diseases. 3. Patient having systemic disease like severe Anemia and Diabetes Mellitus. 4. Infective Vaginal discharges like Bacterial Vaginosis and VulvoVaginal candidiasis. 5. Rectovaginal fistula and Vesicovaginal fistula. 6. Known case of Malignant conditions of female reproductive system. 7. Uterine prolapse and acquired retroverted uterus. 8. Cervical lesion like chronic Cervicitis, Cervical ectropion and mucous polyp. 9. Vaginal discharge occurring due to Intrauterine contraceptive device (IUCDs)

Design outcomes

Primary

MeasureTime frame
To Assess the effect of oral consumption of Amalaki beej kalka with Madhu and Sharkara in management of Shweta pradara.Timepoint: Amalaki beeja kalka will be administered orally Schedule - once a day Duration -3 days Follow up - Follow up will be taken for two consecutive weeks and final follow up will be taken after 15 days.

Secondary

MeasureTime frame
To Assess the effect of oral consumption of Amalaki beej kalka with Madhu and Sharkara in management of Shweta pradara.Timepoint: Amalaki beeja kalka will be administered orally Schedule - once a day Duration -3 days Follow up - Follow up will be taken for two consecutive weeks and final follow up will be taken after 15 days.

Countries

India

Contacts

Public ContactDrPadmaja Kale

YMT Ayurvedic Medical College and Hospital Sector 4, Kharghar, Navi Mumbai

dr.mayuramd2@gmail.com8108103035

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026